FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4304080654> ?p ?o ?g. }

• W4304080654 endingPage "610" @default.
• W4304080654 startingPage "606" @default.
• W4304080654 abstract "Inotersen is an antisense oligonucleotide inhibitor licensed for the treatment of polyneuropathy complicating hereditary transthyretin amyloidosis (ATTRv). Nephrotoxicity has been reported with inotersen, including progression to kidney failure. We describe what is to our knowledge the first reported case of inotersen-associated nephrotic syndrome secondary to focal segmental glomerulosclerosis (FSGS) and review the literature concerning inotersen-induced nephrotoxicity. We report a woman in her early 30s with ATTRv associated with the V50M transthyretin (TTR) variant, who presented with nephrotic syndrome 7 months after commencement of inotersen. Renal histology demonstrated FSGS and scanty glomerular amyloid deposition. Discontinuation of inotersen alone resulted in complete clinical and biochemical resolution of nephrotic syndrome. Inotersen is associated with significant nephrotoxicity. In the phase 3 NEURO-TTR clinical trial, 3% of patients in the treatment arm developed a crescentic glomerulonephritis. All affected patients carried the V50M TTR variant, which is known to be associated with renal amyloid deposition. This case adds to the spectrum of kidney disease associated with inotersen and indicates that discontinuation of the drug alone may result in resolution of renal complications without additional immunosuppression. Monitoring of kidney function is essential in patients with ATTRv receiving inotersen, particularly if there is evidence of existing renal amyloid." @default.
• W4304080654 created "2022-10-10" @default.
• W4304080654 creator A5007011827 @default.
• W4304080654 creator A5038970754 @default.
• W4304080654 creator A5050123012 @default.
• W4304080654 creator A5050125018 @default.
• W4304080654 creator A5050537056 @default.
• W4304080654 creator A5057365396 @default.
• W4304080654 creator A5067688054 @default.
• W4304080654 creator A5072582268 @default.
• W4304080654 creator A5076688617 @default.
• W4304080654 creator A5089708747 @default.
• W4304080654 date "2023-05-01" @default.
• W4304080654 modified "2023-09-30" @default.
• W4304080654 title "Focal Segmental Glomerulosclerosis Complicating Therapy With Inotersen, an Antisense Oligonucleotide Inhibitor: A Case Report" @default.
• W4304080654 cites W2004791868 @default.
• W4304080654 cites W2045487450 @default.
• W4304080654 cites W2076431356 @default.
• W4304080654 cites W2079661108 @default.
• W4304080654 cites W2101817311 @default.
• W4304080654 cites W2117224856 @default.
• W4304080654 cites W2117942418 @default.
• W4304080654 cites W2234725241 @default.
• W4304080654 cites W2337532627 @default.
• W4304080654 cites W2809989268 @default.
• W4304080654 cites W2810909862 @default.
• W4304080654 cites W2887625127 @default.
• W4304080654 cites W2963912856 @default.
• W4304080654 cites W2971637923 @default.
• W4304080654 cites W3016121819 @default.
• W4304080654 cites W3048788919 @default.
• W4304080654 cites W3177445623 @default.
• W4304080654 doi "https://doi.org/10.1053/j.ajkd.2022.08.018" @default.
• W4304080654 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36228827" @default.
• W4304080654 hasPublicationYear "2023" @default.
• W4304080654 type Work @default.
• W4304080654 citedByCount "1" @default.
• W4304080654 countsByYear W43040806542023 @default.
• W4304080654 crossrefType "journal-article" @default.
• W4304080654 hasAuthorship W4304080654A5007011827 @default.
• W4304080654 hasAuthorship W4304080654A5038970754 @default.
• W4304080654 hasAuthorship W4304080654A5050123012 @default.
• W4304080654 hasAuthorship W4304080654A5050125018 @default.
• W4304080654 hasAuthorship W4304080654A5050537056 @default.
• W4304080654 hasAuthorship W4304080654A5057365396 @default.
• W4304080654 hasAuthorship W4304080654A5067688054 @default.
• W4304080654 hasAuthorship W4304080654A5072582268 @default.
• W4304080654 hasAuthorship W4304080654A5076688617 @default.
• W4304080654 hasAuthorship W4304080654A5089708747 @default.
• W4304080654 hasBestOaLocation W43040806541 @default.
• W4304080654 hasConcept C126189478 @default.
• W4304080654 hasConcept C126322002 @default.
• W4304080654 hasConcept C126894567 @default.
• W4304080654 hasConcept C142724271 @default.
• W4304080654 hasConcept C159641895 @default.
• W4304080654 hasConcept C2778415529 @default.
• W4304080654 hasConcept C2778653478 @default.
• W4304080654 hasConcept C2778715236 @default.
• W4304080654 hasConcept C2778930706 @default.
• W4304080654 hasConcept C2779951007 @default.
• W4304080654 hasConcept C2780091579 @default.
• W4304080654 hasConcept C2780368995 @default.
• W4304080654 hasConcept C71924100 @default.
• W4304080654 hasConcept C90924648 @default.
• W4304080654 hasConceptScore W4304080654C126189478 @default.
• W4304080654 hasConceptScore W4304080654C126322002 @default.
• W4304080654 hasConceptScore W4304080654C126894567 @default.
• W4304080654 hasConceptScore W4304080654C142724271 @default.
• W4304080654 hasConceptScore W4304080654C159641895 @default.
• W4304080654 hasConceptScore W4304080654C2778415529 @default.
• W4304080654 hasConceptScore W4304080654C2778653478 @default.
• W4304080654 hasConceptScore W4304080654C2778715236 @default.
• W4304080654 hasConceptScore W4304080654C2778930706 @default.
• W4304080654 hasConceptScore W4304080654C2779951007 @default.
• W4304080654 hasConceptScore W4304080654C2780091579 @default.
• W4304080654 hasConceptScore W4304080654C2780368995 @default.
• W4304080654 hasConceptScore W4304080654C71924100 @default.
• W4304080654 hasConceptScore W4304080654C90924648 @default.
• W4304080654 hasIssue "5" @default.
• W4304080654 hasLocation W43040806541 @default.
• W4304080654 hasLocation W43040806542 @default.
• W4304080654 hasLocation W43040806543 @default.
• W4304080654 hasLocation W43040806544 @default.
• W4304080654 hasOpenAccess W4304080654 @default.
• W4304080654 hasPrimaryLocation W43040806541 @default.
• W4304080654 hasRelatedWork W1969386754 @default.
• W4304080654 hasRelatedWork W1987388617 @default.
• W4304080654 hasRelatedWork W1998705322 @default.
• W4304080654 hasRelatedWork W2027719409 @default.
• W4304080654 hasRelatedWork W2030093353 @default.
• W4304080654 hasRelatedWork W2093874596 @default.
• W4304080654 hasRelatedWork W2167942688 @default.
• W4304080654 hasRelatedWork W2184922026 @default.
• W4304080654 hasRelatedWork W2408829444 @default.
• W4304080654 hasRelatedWork W4323545991 @default.
• W4304080654 hasVolume "81" @default.
• W4304080654 isParatext "false" @default.
• W4304080654 isRetracted "false" @default.

• next